It is becoming more difficult for Novo to make money
Novo Nordisk has lowered its long-term target for growth in operating result significantly. The reason is not lower sales expectations, but rather a recognition that it is becoming increasingly difficult for the group to increase profitability.
BY STEFAN SINGH KAILAY
Novo Nordisk has a new target for the future. The company’s long-term financial target was set to take center stage ahead of Wednesday’s presentation of the annual report for 201, and it did.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Danish agency advises against use of Saxenda
For abonnenter
“This is not normal for Novo Nordisk”
For abonnenter
